0334 GMT - QBE Insurance loses its bull at UBS, where analysts think that reserve releases are unlikely to counter margin pressures. Cutting the investment bank's recommendation on the stock to neutral from buy, the analysts tell clients that they see only limited release capacity. They believe that QBE's U.S. surplus has moderated since fiscal 2022 despite top-ups, and flag declining international reserve ratios. In Asia-Pacific, they warn that releases driven by compulsory third-party motor insurance and lenders mortgage insurance could be hard to sustain. The analysts say a recent rerate was justified, but are skeptical on further upside. UBS lifts its target price 8.1% to 27.30 Australian dollars. Shares are down 0.2% at A$25.41. (stuart.condie@wsj.com)
(END) Dow Jones Newswires
July 20, 2026 23:34 ET (03:34 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.